<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Twenty patients with <z:hpo ids='HP_0100601'>eclampsia</z:hpo> were studied for the presence of anticardiolipin antibodies by the standard microflocculation test (quantitative) used in the VDRL </plain></SENT>
<SENT sid="1" pm="."><plain>Four out of 20 patients (20%) were positive for anticardiolipin antibodies </plain></SENT>
<SENT sid="2" pm="."><plain>Anticardiolipin antibodies which are <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> by decreasing the prostacyclin production may damage the vascular endothelium and cause <z:mp ids='MP_0005048'>thrombosis</z:mp> in the vessels </plain></SENT>
<SENT sid="3" pm="."><plain>Hence, the presence of anticardiolipin antibody in <z:hpo ids='HP_0100601'>eclampsia</z:hpo> may have association with <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome described by Harris et al </plain></SENT>
<SENT sid="4" pm="."><plain>(Lancet ii: 1211, 1983) and its central <z:mp ids='MP_0008912'>nervous</z:mp> system sequelae </plain></SENT>
</text></document>